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Palavras-chave Lesão medular; mínima diferença de importância clínica, pico de fluxo, 
atividades da vida diária  
Resumo Introdução: As lesões medulares (LM) são atualmente um problema de 
saúde pública mundial. A dor, a fadiga, a redução do fluxo expiratório e 
da eficácia da tosse e o aumento da dispneia são sinais e sintomas 
frequentes, que contribuem para o aumento do risco de infeções 
respiratórias. As infeções respiratórias constituem a principal causa de 
morte nestes doentes e podem ser prevenidas, desde que exista uma 
monitorização regular. As Mínimas diferenças de importância clínica 
(MDICs) de instrumentos de medida são essenciais, para interpretar os 
resultados desta monitorização e orientar a intervenção, mas são 
escassas as que se encontram estabelecidas para doentes com LM que 
realizam programas de reabilitação.  
Objetivo: Determinar as MDICs para a Escala Numérica da Dor (END), 
Pico de Fluxo Expiratório (PFE), Pico de Fluxo de Tosse (PFT), Escala 
de Severidade da Fadiga (ESF), e Escala London Chest Activities of 
Daily Living (LCADL) em doentes com LM após reabilitação. 
Métodos: A END, PFE, PFT, ESF e LCADL foram aplicadas na 
admissão e no momento da alta dos doentes do Centro de Medicina e 
Reabilitação de Alcoitão que realizaram programa de reabilitação. A 
escala de perceção global de mudança (EPGM) foi aplicada no 
momento de alta. As MDICs foram calculadas através de métodos de 
âncora (característica de operação do recetor e regressão linear) e de 
distribuição (erro padrão da medida (EPM), 1,96 vezes o EPM, 0,5 vezes 
o desvio-padrão e a mínima diferença detetável). As MDICs finais foram 
calculadas agrupando os métodos de âncora e de distribuição. 
Resultados: Trinta e um doentes com LM participaram no estudo (17 
homens; 55±16,2 anos). Foi encontrada uma correlação significativa 
entre a END e a EPGM, resultando numa MDIC, através de métodos de 
âncora, de -1,5 pontos. As MDICs estimadas através de métodos de 
distribuição variaram de 0,8 a 2.3 pontos para a END, 37 a 102,6 L/min 
para o PFE, 59,4 a 166,5 L/min para o PFT, 0,6 a 1,8 pontos para a ESF, 
e de 0,6 a 2 pontos para a LCADL.  
Conclusão: Melhorias que excedam as estimativas de -1,6 pontos para 
a END, 67,1 L/min para o PFE, 100,9 L/min para o PFT, 1,1 pontos para 
a ESF, e 1,4 pontos para a LCADL devem ser considerados 
clinicamente relevantes para doentes com LM após reabilitação.  
  
 
 
  
  
 
Keywords Spinal cord injury; minimal clinically important difference; peak flow; 
activities of daily living 
Abstract Introduction: Spinal cord injuries (SCIs) represent a major public health 
problem. Pain, fatigue, reduced expiratory flow and cough efficacy and 
increased dyspnoea are frequent signs and symptoms that contribute to 
the increased risk of having respiratory infections. Respiratory infections 
are the most common cause of mortality and morbidity in this population, 
but can the prevented if regular monitoring of these patients is 
performed. Minimal clinically important differences (MCIDs) of outcome 
measures are essential to interpret results of this monitoring and guide 
interventions, but MCIDs established for patients with SCI after 
rehabilitation programmes are missing.  
Aim: To determine MCIDs for the numerical pain rating scale (NPRS), 
peak expiratory flow (PEF), peak cough flow (PCF), fatigue severity 
scale (FSS), and London chest activities of daily living scale (LCADL) in 
patients with SCI after rehabilitation. 
Methods: The NPRS, PEF, PCF, FSS and LCADL were performed at 
baseline and at discharge of patients who underwent a rehabilitation 
programme treatment at the Medicine and Rehabilitation Centre of 
Alcoitão. The global rating of change (GRC) scale was performed at 
discharge. MCIDs were calculated using anchor (receiver operating 
characteristic and linear regression analysis) and distribution-based 
methods (standard error of measurement (SEM), 1.96 times SEM, 0.5 
standard deviation and minimal detectable change) and pooled using 
Meta XL.  
Results: Thirty-one inpatients with SCI (17 males; 55±16.2 years) 
participated. A significant correlation with GRC was found for the NRS 
resulting in an anchor-based MCID estimate of -1.5 points. Distribution-
based MCIDs estimates ranged from 0.8 to 2.3 points for the NPRS, 37 
to 102.5 L/min for PEF, 59.4 to 166.5 L/min for PCF, 0.6 to 1.8 points for 
the FSS, and 0.6 to 2 points for the LCADL.  
Conclusion: Improvements exceeding the pooled MCID estimate of -
1.6 points on the NPRS, 67.1 L/min on the PEF, 100.9 L/min on the PCF, 
1.1 points on the FSS, and 1.4 points on the LCADL should be 
considered clinically relevant for patients with SCI after rehabilitation. 
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INTRODUCTION 
Spinal cord injuries (SCIs) represent a major public health problem that leads to 
significant disabilities in patients and affects not only the patients themselves but also 
their family and, ultimately, the society as a whole (van den Berg, 2010). Traumatic SCIs 
are mostly caused by road traffic accidents and falls, affecting 10.5 per 100000 people 
worldwide (Jazayeri, Beygi, Shokraneh, Hagen, & Rahimi-Movaghar, 2015; Kumar et al., 
2018). Non-traumatic SCIs are commonly associated with age-related problems and 
affect approximately 11.4 per 1000000 people in Spain. However, this incidence has not 
been widely studied (van den Berg, Castellote, Mahillo-Fernandez, & de Pedro-Cuesta, 
2012). 
After SCI, 36 – 83 % of the patients are affected by respiratory complications, the 
most common cause of death in this population, twice the expected rate for a same age 
person without SCI (Tollefsen & Fondenes, 2012; Lidal at al., 2007). Respiratory failure 
and retention of secretions represent significant complications (Hagen, Eide, Rekand, 
Gilhus, & Gronning, 2010). 
As higher is the neurological level of the injury, greater is the reduction of 
pulmonary function parameters, leading to a reduced ability to cough and to clear 
airways, atelectasis, impaired gas exchange and respiratory infections (Linn et al., 2001; 
Brown, DiMarco, Hoit, & Garshick, 2006; Schilero, Spungen, Bauman, Radulovic, & 
Lesser, 2009; Schilero, Bauman, & Radulovic, 2018). Respiratory infections have a 
negative effect on the physical independence and long-term survival of patients with SCI, 
irrespective of age and severity (Kopp et al., 2017). Additionally, findings from a 5-year 
follow-up study showed that beyond respiratory function impairments and reduced ability 
to cough (30.9% of the patients had a forced vital capacity (FVC) below the 80% 
predicted value, 35.9% poor or moderate self-reported cough strength), 18.4% of the 
patients reported rest dyspnoea and 29.0% during activity, being associated with worse 
health-related quality of life (Postma et al., 2016). Patients with SCI also report pain and 
fatigue as relevant symptoms, with a statistically signiﬁcant negative association with 
reduced mobility, participation, and satisfaction with life (Marcondes et al., 2016; Smith 
et al., 2016).  
The pertinence of these signs and symptoms, and the mortality and morbidity 
associated with respiratory complications in patients with SCI demand appropriate 
monitoring, prevention and treatment ( Schilero et al., 2018; Tollefsen & Fondenes, 2012; 
Wyndaele & Wyndaele, 2006; Anton et al., 2017; Kopp et al., 2017). 
According to a report from the European Spinal Cord Injury Federation about 
primary rehabilitation services offered to people with SCI, most of the patients are cared 
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for in specialized SCI hospitals, units, or centres, with multidisciplinary teams, focused 
on achieving their maximum functional potential and independence, overtaking the 
barriers of societal reintegration (Horsewell, 2007).  
Physiotherapy for patients with SCI comprises a comprehensive assessment and 
intervention, focusing on different problems in many body systems, including respiratory 
and sensorimotor function, impact on functionality and pain (Harvey, 2016). It plays a 
key role to address the described needs of patients with SCI and is part of the 
fundamental rehabilitation process that should start as soon as the patient is medically 
stable (Fehlings, Tetreault, Wilson, et al., 2017; Harvey, 2016).  
The use of outcome measures during a rehabilitation intervention is essential to 
monitor patients’ evolution however, clinically relevant improvements are difficult to 
interpret in the absence of minimal clinically important differences (MCIDs) (Ekstrom et 
al., 2015). 
The MCID is defined as the smallest change in health-related scores that is 
perceived as meaningful by patients, being specific for each outcome measure and 
population (Ekstrom, Currow, & Johnson, 2015). MCIDs for the neck disability index, the 
oswestry disability index, the physical component summary of the 36-item short form of 
the medical outcome measures, the physical and mental component summaries of the 
12-item short form health survey, EuroQol-5D health survey, the numerical rating scale 
for back and for leg pain, the visual analogue scale have been determined for patients 
with SCI after undergoing surgery (Parker et al., 2013; Copay et al, 2008; Parker et al, 
2012). MCID for the spinal cord independence measure III was established after 
rehabilitation in spinal cord units (Corallo et al., 2017). Minimal important difference (MID) 
for the walking index for SCI and gait speed were established for patients with incomplete 
SCI, after an out-patient body weight-supported treadmill training programme 
(Musselman, 2007). However, MCID for other outcome measures commonly used in 
rehabilitation including physiotherapy interventions of patients with SCI are lacking and 
are urgently needed to monitor and interpret patients’ progress and guide personalised 
interventions.  
This study aimed to determine MCIDs for numerical pain rating scale (NPRS), 
peak expiratory flow (PEF), peak cough flow (PCF), fatigue severity scale (FSS), and 
London chest activities of daily living scale (LCADL) in patients with SCI after a 
rehabilitation programme. 
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METHODS 
Ethical approval 
This study was approved by the Ethical Commission of the Medicine and 
Rehabilitation Centre of Alcoitão (MRCA) on the 21th May of 2018 (CMRA 04) (Annex I). 
Written informed consent (Appendix I) was obtained from all participants before any data 
collection. 
Study design and recruitment 
An observational prospective study was conducted from May to November of 
2018 in patients with SCI admitted to the MRCA.  
Participants were first identified by the investigator according to the eligibility 
criteria. Patients were considered eligible for the study if they were at least 18 years old, 
had a diagnosis of SCI (without limitations about the time or extension of the injury), were 
currently inpatients at the MRCA, and were able to understand and speak Portuguese 
and to give an informed consent to participate. Patients were excluded if they presented: 
signs of mental disorders or cognitive impairments; neurological, cardiovascular, or 
respiratory function limitations previous to the SCI; and thorax or spine’s structural 
injuries being managed; that could affect or preclude them of participating in data 
collection (Chan et al., 2018; Mueller, Hopman, & Perret, 2013; Roth et al., 2010; Tamplin 
et al., 2013). The investigator informed eligible participants about the study, and gave 
them a Participant Information Sheet (Appendix II). Only those interested to participate 
were included for further assessments. 
 
Data Collection 
Patients were assessed within two weeks of admission and at discharge from the 
MRCA. Each evaluation session lasted approximately 20 minutes and was performed at 
the MRCA. All measures were collected by an experienced physiotherapist except the 
lung function, maximal inspiratory pressure (MIP) and maximal expiratory pressure 
(MEP), which were collected by a trained cardiopulmonary technician. Patients were 
admitted for approximately 60 days. 
The following data were collected only at baseline to characterise the population. 
A structured questionnaire based on International Classification of Functionality (ICF) 
checklist and American Spinal Injury Association (ASIA)/ International Spinal Cord 
Society working group, which included sociodemographic (i.e., age, weight, height, body 
mass index gender, education, current occupation, marital status), and general clinical 
data (i.e., smoking status, comorbidities, respiratory complications in the last year, 
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ventilatory assistance, medication, time and cause of the SCI) was first applied (DeVivo, 
2017; Krassioukov A., 2010; WHO, 2010). 
The Charlson Comorbidity Index (CCI) was calculated to measure disease 
burden, using the updated version from 2010 (Quan et al., 2011). CCI have been used 
in patients with SCI (Bertling et al., 2016; Burns, Weaver, Chin, Svircev, & Carbone, 
2016). Each comorbid condition was weighted according to the related risk of mortality 
in one year: congestive heart failure – 2 points; dementia – 2 points; chronic pulmonary 
disease – 1 point; rheumatologic disease – 1 point; mild liver disease – 2 points/ 
moderate or severe liver disease – 4 points; diabetes with chronic complications – 1 
point; hemiplegia or paraplegia – 2 points; renal disease – 1 point; any malignancy, 
including leukaemia and lymphoma – 2 points/ metastatic solid tumour – 6 points, 
acquired immunodeﬁciency syndrome or human immunodeﬁciency virus – 4 points 
(Quan et al., 2011). All points are summed, and the total score can range from 0-24 
points, a higher score means a greater disease burden and predicts an earlier mortality 
(Quan et al., 2011). The total score was classified as mild – CCI ≤2, moderate – 2<CCI≤4, 
or severe – CCI≥5 (Charlson, Pompei, Ales, & MacKenzie, 1987). 
The Portuguese version of the International standards for neurological 
classification of spinal cord injury (ISNCSCI) was used to categorise the injury extension 
(Fehlings, Tetreault, Wilson, et al., 2017; Kirshblum, 2011). The ISNCSCI is divided into 
a motor and sensory assessment (Fehlings, Tetreault, Wilson, et al., 2017). The motor 
score was defined by the sum of the left and right upper and lower extremities motor 
scores, evaluating 10 key myotomes (Fehlings, Tetreault, Wilson, et al., 2017). The 
sensory assessment comprised light touch and pin prick sensation tests of the left and 
right dermatomes compared to the patient’s face sensation (Fehlings, Tetreault, Wilson, 
et al., 2017). The neurological level was the lower spinal cord level where both sensory 
and motor function were preserved (Kirshblum, 2011). 
The ASIA Impairment Scale (AIS) was used to classify the injury extension in a 
5-grade classification system. Grade A – complete injury, B – sensory incomplete, C and 
D – motor incomplete, E– normal sensation and motor function (Fehlings, Tetreault, 
Wilson, et al., 2017). 
Lung function was assessed with spirometry and respiratory muscle strength with 
maximal respiratory pressure tests. The equipment was adapted to wheelchair users, 
using a computer with a specialised software (MasterScope version 4.5, JAEGER), in 
conformity with the relevant standards from European Respiratory Society and the 
American Thoracic Society (Jaeger, 1999). A heated pneumotach was connected to the 
MasterScope program, to measure and analyse the lung function and respiratory muscle 
strength (Jaeger, 1999). Absolut and percentage predicted values from FVC, forced 
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expiratory volume in one second (FEV1), FVC/ FEV1 ratio, MIP and MEP were 
registered for each participant (Jaeger, 1999; Miller, 2005). 
The following outcome measures were applied at admission and at discharge: 
NPRS, PEF, PCF, FSS and LCADL. 
The NPRS was used to quantify the perception of the patient about her/his pain 
severity in the worst pain site. The scale is recommended by the Portuguese Health 
General Direction and has been used in other studies with patients with SCI (Copay et 
al., 2008; DeSantana & Sluka, 2009; DGS, 2003). The patient was asked to select the 
number between “0” and “10” that best represented her/his pain. The scale was 
presented as a horizontal sequence of squares with a number inside. Higher numbers 
represent worse pain, i.e., “0” means “no pain” and “10” means “the worst pain you can 
imagine” (DGS, 2003). The NPRS correlates significantly to the pain relief scale (r=0.92) 
(Lee et al., 2015). 
The PEF and PCF were measured using a peak flow meter (PFM) (MicroPeak 
from CareFusion), which is simple and economic instrument. A nose clip was placed on 
the patients nose and patients were asked to inhale as much air as they could, and 
exhale (PEF) as fast and as strong as they could or cough (PCF) through the mouth 
piece of the PFM, in the sitting position. Each assessment was repeated three to five 
times with intervals of 30 seconds, and the best result was recorded for PEF and PCF 
(Tzani et al., 2014). PEF and PCF are two commonly used outcome measures in patients 
with SCI (Postma et al., 2016; Postma et al., 2015; Rose et al., 2018). The PEF is 
considered an excellent discriminator for pneumonia in patients with motor incomplete 
SCI with a risk threshold value of 420 L/min, supporting the relevance of the outcome 
measure for the target population (Raab et al., 2016). The PCF has also been considered 
a relevant measure for patients with SCI, a cut-off value of 270 L/min is recommended 
as clinically important to start techniques to increase cough effectiveness, including lung 
volume recruitment, manually assisted cough, and mechanical insufflation-exsufflation 
devices (Rose et al., 2018). A cut-off value of 160 L/min has been reported as minimum 
to allow an effective airway clearance, considered a specific and sensitive predictor of 
severe respiratory infections and hospital admissions due to respiratory complications 
(Tzani et al., 2014; Bianchi, Baiardi, Khirani, & Cantarella, 2012). 
The Portuguese version of the FSS, was used to measure the severity of the 
fatigue. Each patient was asked to score her/his agreement with eight sentences, 
between “1” – “strongly disagree” and “7” – “strongly agree”, as the authors suggested 
the elimination of item 1, considering eight sentences instead of the nine from the original 
version, presenting better internal consistency (Chronbach’s alpha=0.899) (Gomes, 
2011). Scores were summed and divided by eight, with a possible range of 1 to 7,  a 
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higher score reveals greater fatigue (Gomes, 2011). In the absence of an outcome 
measure validated for the Portuguese population with SCI, the FSS is validated for the 
Portuguese population with multiple sclerosis, and have been used in patients with SCI 
(Fawkes-Kirby et al., 2008; Gomes, 2011; Nooijen et al., 2015). The FSS has an 
excellent internal validity, revealing a moderate and positive significant correlation 
(r=0.74) with the visual analogue scale applied to assess fatigue severity (Gomes, 2011).  
The portuguese version of the LCADL, was used to assess dyspnoea during 
activities of daily living (ADL). The LCADL contains 15 items divided in four components: 
self-care, domestic, physical, and leisure. Each patient was asked to score how much 
dyspnoea interferes, to each ADL in a scale from 0 to 5: “0” – I would not do it anyway 
(or motor control does not allow), “1” – I have no lack of air doing this, “2” – I have a slight 
lack of air, “3” – I have a great lack of air, “4” – I no longer do this, “5” – I need help in 
doing this or someone to do it for me (“4” and “5”because of dyspnoea) (Pitta et al., 
2008). The final score was calculated by summing every item of the scale in each of the 
components with a possible range of 0 to 75. In the absence of an outcome measure 
validated for Portuguese patients with SCI, the LCADL is validated for patients with 
chronic obstructive pulmonary disease (COPD) and has been reported to be adjustable 
to different levels of motor impairment due to SCI (Pitta et al., 2008). The LCADL has 
adequate psychometric properties, showing a strong test-retest reliability (intraclass 
correlation coefficient (ICC)=0.98) and internal consistency (Cronbach’s alpha=0.86) 
(Pitta et al., 2008). Positive poor to moderate significant correlations have been reported 
between the LCADL total score and each section and total score of the Saint George 
Respiratory Questionnaire components (0.36<r<0.74; p<0.05), and a negative moderate 
significant correlation between the LCADL total score and the 6 minutes walking test 
distance (r=-0.48; p=0.006) (Pitta et al., 2008). 
The global rating of change (GRC) scale was used to assess the perception of 
change for each outcome measure used at discharge. In order to optimise interpretability 
and reliability, GRC questions were designed for each outcome measure according to 
the best evidence available, i.e., mentioning the specific condition, the concept, and the 
time frame (Kamper, Maher, & Mackay, 2009). Patients were asked to quantify their 
perception about each measure’s change, comparing discharge to the admission, in a 
balanced 11-point numerical scale with written descriptors at the ends (“-5” – “much 
worst”, and “5” – “much better”) and at the midpoint (“0” – “without changes”) (Kamper, 
Maher, & Mackay, 2009). The GRC has been used before in patients with SCI (Stewart, 
Maher, Refshauge, Bogduk, & Nicholas, 2007) and significant and moderate correlations 
have been reported between the GRC and the magnitude of change scored by subjective 
self-report measures as the NPRS (r=0.49, area under the curve (AUC)=0.68) (Stewart 
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et al., 2007). The 11-point GRC has shown an adequate reproducibility, with excellent 
ICC2,1 (ICC=0.90), and a good sensitivity to change (minimum detectable change of 0.45 
points and MID=2 points) in patients with chronic low back pain (Costa et al., 2008). 
 
Intervention 
The intervention was tailored to each patient and included: one to three hours/day 
of physiotherapy; one hour/day of occupational therapy; thirty minutes/day of ADL 
training; thirty minutes/week of psychology; pharmacological therapy; medical; nursery; 
and social assistance support. 
The physiotherapy intervention was individually planned and focused in the 
following components: 
- Respiratory management enhancing thoracic expansion, breathing control, 
respiratory muscle training, and airway clearance techniques to prevent 
complications, such as atelectasis and pneumonia, and achieve the best 
possible exercise tolerance (Berlowitz & Tamplin, 2013; Fehlings, Tetreault, 
Wilson, et al., 2017; Reid, Brown, Konnyu, Rurak, & Sakakibara, 2010); 
- Bobath concept, an inclusive, personalised problem-solving approach, based 
on contemporary principles of motor control, neuromuscular plasticity and 
motor learning, emphasising movement analysis and recovery through the 
integration of sensory information, postural control and task performance; 
with the final purpose of optimising the movement selectivity, activity, 
participation and quality of life of neurological patients (Vaughan-Graham, 
Cott, & Wright, 2015a, 2015b). 
- Sensorial stimulation, crucial to guide postlesional neuroplasticity, and 
movement facilitation, a selective manipulation of sensory input to enhance 
motor control and perception (Gjelsvik B., 2016; Vaughan-Graham et al., 
2015b); 
- Pain relief techniques to avoid maladaptive plastic changes involved in the 
development of neuropathic pain and allodynia (Onifer, Smith, & Fouad, 
2011); 
- Exercise to enhance positive plastic changes, including aerobic, strength, 
flexibility, and postural control training (Harvey, 2016; Rank et al., 2015; van 
Langeveld et al., 2011); 
- Neuromuscular electrical stimulation, to enhance motor function (Fehlings, 
Tetreault, Aarabi, et al., 2017; Harvey, 2016); 
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- Motor skills training including wheelchair abilities and walking, respecting the 
functional potential of the patients, to improve their functionality (Gjelsvik B., 
2016; Harvey, 2016); 
- Education of the patient and carers, to facilitate discharge and maintenance 
of the improvements (Harvey, 2016). 
If in the best judgement of the physiotherapist, she/he considered relevant, 
additional therapy resources could be used such as:  body weight-supported treadmill 
training (promoting plasticity in an activity-dependent manner), lokomat robotic walking 
training, exoskeleton walking training, and aquatic physiotherapy (if the patient had 
sphincters control) (Ellapen, Hammill, Swanepoel, & Strydom, 2018; Fehlings, Tetreault, 
Aarabi, et al., 2017; Gjelsvik B., 2016; Harvey, 2016). 
 
Statistical Analysis  
SPSS software Version 24.0 (IBM Corporation, Armonk, NY, USA) and Meta XL 
5.3 (EpiGear International, Queensland, Australia) for Windows were used for statistical 
analysis. The significance level was set at 0.05. 
Descriptive statistics were used to describe the sample, baseline characteristics 
were expressed as relative frequencies, mean and standard deviation for normally 
distributed data or median and interquartile range for non-normally distributed data. The 
Shapiro-Wilk test was used to assess normality of data distribution. The analysis of 
outliers was achieved by plotting the studied variables (i.e., NPRS, PEF, PCF, FSS, and 
LCADL) on a graph and visually inspect for extreme points and outliers were removed 
for MCID analysis (Aggarwal & Ranganathan, 2016). Significance of changes between 
admission and discharge were calculated with paired t-tests for normally distributed data 
or Wilcoxon signed-rank tests for otherwise (Chan et al., 2018).  
The best way to measure MCID has not been defined yet, however it has been 
commonly recommended to use anchor- and distribution-based techniques (Alma et al., 
2016; Chan et al., 2018; Oliveira, Machado, & Marques, 2018). Thus, both techniques 
were applied in this study to determine the proposed MCIDs (Ekstrom et al., 2015). 
Anchor based methods were calculated through patient-referencing methods, 
using the GRC as an anchor, when significant correlations, tested with the Pearson rank 
correlation, were equal or superior to 0.3 in the selected outcome measures (i.e., NPRS, 
PCF, PEF, FSS, and LCADL) (Chan et al., 2018; Oliveira et al., 2018; Revicki, Hays, 
Cella, & Sloan, 2008). A GRC total score of two points improvement was used as the 
MID for the GRC (Alma et al., 2016; Kamper et al., 2009). MCIDs were calculated using 
linear regression analysis and receiver operating characteristic (ROC) curves. For linear 
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regression analysis, the statistically significant equations were used to estimate the 
MCID of the respective outcome measure corresponding to the MID improvement of the 
GRC (+2). For each ROC curve, the AUC and respective 95% confidence intervals were 
obtained and the pair of coordinates where the sensitivity and specificity were 
simultaneously maximised were chosen for the MCID of each outcome measure (Oliveira 
et al., 2018). 
Distribution-based methods used to estimate MCID were the 0.5 times the 
baseline standard deviation (0.5SD); standard error of measurement (SEM) calculated 
as SEM= baseline SD x √(1−ICC); 1.96 times SEM (1.96SEM) and minimal detectable 
change at the 95% level of confidence (MDC95) calculated as MDC95= 1.96 x SEM x 
√2 (Copay et al., 2008; Oliveira et al., 2018; Revicki et al., 2008). The intraclass 
correlation coefficient used for the SEM calculation was based on the reliability studies 
previously published for each outcome (i.e., 0.95 for the NPRS (Copay et al., 2008); 0.87 
for the PEF (Fonseca et al., 2005); 0.746 for the PCF (Tzani et al., 2014); 0.899 for the 
FSS (Gomes, 2011); 0.98 for the LCADL and 0.96, 0.99, 0.92, 0.95 for the respective 
sections: self-care, domestic, physical, and leisure (Pitta et al., 2008). 
The pooling of data was performed based on what has been previously described (Alma 
et al.,2016; Oliveira et al., 2018). MCIDs estimated with each of the anchor- and 
distribution-based methods for the PEF, PCF, FSS, NPRS and LCADL were pooled 
using Meta XL 5.3. The input data were the estimated MCID with each method and 
respective confidence interval, when appropriated. Since anchor-based methods are 
considered to be more adequate for establishing clinical significance than distribution-
based methods, a quality effects model was used in which anchor methods weighted 2/3 
and distribution methods weighted 1/3 for the final pooled MCID (Alma et al., 2018; 
Oliveira et al., 2018). 
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RESULTS 
Patient characteristics and health status 
In total, 31 patients with SCI were referred for the study and included for baseline 
assessment. However, three patients did not complete the study due to unexpected 
discharges. Therefore, 28 patients with a mean intervention time of 7.5 ± 1.4 weeks were 
included in the final analysis. A flow diagram of the included sample is provided in Figure 
1. 
 
Figure 1. Flow diagram of the included sample of patients with spinal cord injury. 
 
Baseline characteristics of the included patients with SCI are shown in Table 1. 
Patients were aged 55 ± 16.2 years old. Most of them were male (n=17; 54.8) with 4 
years of education (n=8; 25.8%), were retired (n=14; 45.2%), married (n=16; 51.8%) and 
were former smokers (n=16; 51.8%).  
At baseline, lung function tests could only be completed by 27 patients and 
maximal respiratory pressures tests by 26 patients due to the inadaptation to the mouth 
piece of the pneumotachograph. Overall, patients presented normal lung function (mean 
FEV1 %predicted=80.9 ± 20.1; FVC %predicted=78.5 ± 19.8; FEV1/FVC=85.1 ± 9.8) and 
almost half of the maximal respiratory pressure values predicted (MIP %predicted=59.3 
± 21.7; MEP %predicted=57.9 ± 20.4).  
Mean comorbidities per patient was 2±1.4, 67.7%, meaning a mild CCI (n=21). 
Only two patients presented respiratory exacerbations during the past 12 months and no 
patients used non-invasive ventilation. Patients were taking a mean of 9.3±3.6 
medicines, being the most common modifiers of intestinal motility (n=29; 93.5%); 
modifiers of gastric secretion (n=23; 74.2%); antidepressants (n=21; 67.7%); anxiolytics, 
sedatives, and hypnotics (n=16; 51.6%); and drugs for urinary problems (n=15; 48.4%). 
31 patients included 
at baseline assessment
28 patients included 
3 patients discharged 
before final assessment
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The most common type of SCI was traumatic (n=17; 54.8%) classified as D (i.e., 
motor incomplete) according to the AIS (n=13; 41.9%), and of cervical neurological level 
(n=16; 51.8%). 
Table 1. Baseline characteristics of the included patients with spinal cord injury (n=31). 
Characteristics Baseline  
Age (years) 55 ± 16.2 
BMI (kg/m2) 25.9 ± 4.7 
Gender 
   Male 
   Female 
Education 
 
17 (54.8) 
14 (45.2) 
 
   Illiterate 
   4th year 
   6th year 
   9th year 
   12th year 
   Higher education 
4 (12.9) 
8 (25.8) 
5 (16.1) 
5 (16.1) 
3 (9.7) 
6 (19.4) 
Current occupation 
   Retired  
   Sick leave 
   Student  
   Housework 
   Unemployed 
   Remunerated work 
 
14 (45.2) 
11 (35.5) 
2 (6.5) 
2 (6.5) 
1 (3.2) 
1 (3.2) 
Marital status  
   Married 
   Single 
   Unmarried couple 
   Widower 
   Divorced 
   Separated 
16 (51.8) 
8 (25.8) 
2 (6.5) 
2 (6.5) 
2 (6.5) 
1 (3.2) 
Smoking status  
   Former 
   Never 
   Current 
16 (51.8) 
12 (38.7) 
3 (9.7) 
Lung function 
   FEV1 %predicted (n=27) 
 
80.9 ± 20.1  
   FVC %predicted (n=27) 78.5 ± 19.8  
   FEV1/FVC (n=27) 
Respiratory muscle strength 
85.1 ± 9.8  
   MIP %predicted (n=26) 59.3 ± 21.7  
   MEP %predicted (n=26) 
Comorbidities 
   Number of comorbidities  
   Charlson Comorbidity Index  
      Mild 
      Moderate  
      Severe  
Respiratory exacerbations during the past 12 months 
    0 
    1 
Ventilation 
57.9 ± 20.4 
 
2 ± 1.4 
 
21 (67.7) 
9 (29.0) 
1 (3.2) 
 
29 (93.5)  
2 (6.5) 
 
   Non-invasive ventilation 0 (0) 
Medication  
   Medicine per patient 
   Pharmacotherapeutic group 
 
9.3 ± 3.6 
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      Modifiers of intestinal motility, Propulsives       
      Modifiers of gastric secretion 
      Antidepressants 
      Anxiolytics, hypnotics and sedatives 
      Drugs for urinary problems 
      Antiepileptics and anticonvulsants 
      Centrally acting muscular relaxants 
      Anti-thrombotics 
      Vitamins 
      Renin-angiotensin-system-acting agents 
      Antipsychotics 
      Antidyslipidemics 
      Other antidiabetics 
      Venotropics 
      Antibacterial 
      Analgesics and antipyretics 
      Opioid analgesics 
      Adrenoreceptor antagonists 
      Anti-anaemics 
      Drugs for the treatment of haemorrhoids  
      Thyroid and antithyroid preparations 
      Gynaecological anti-infectives 
      Diuretics 
      Calcium channel blockers 
      Adrenergic inhalants 
      Antifungal 
      Modifiers of gastric motility or prokinetics 
      Nonsteroidal anti-inflammatory drugs 
      Drugs for the treatment of arthrosis 
      Bisphosphonates 
      Calcium 
      Peripherally acting muscular relaxants 
      Antiemetic and antinauseants 
      Repolarization prolongers antiarrhythmics 
      Other antihypertensives 
      Vasodilators 
      Other vasodilators 
      Digestive antispasmodics 
      Enzyme supplements, lactobacillus, and analogues 
      Choleretic and cholagogues 
      Drugs for erectile dysfunction 
      Insulins 
      H1 non-selective histamines 
      Sodium 
      Immunomodulators 
      Dressings for chronic wounds 
29 (93.5) 
23 (74.2) 
21 (67.7) 
16 (51.6) 
15 (48.4) 
14 (45.2) 
12 (38.7) 
11 (35.5) 
10 (32.3) 
8 (25.8) 
7 (22.6) 
7 (22.6) 
7 (22.6) 
5 (16.1) 
4 (12.9) 
4 (12.9) 
4 (12.9) 
4 (12.9) 
4 (12.9) 
4 (12.9) 
4 (12.9) 
5 (16.1) 
3 (9.7) 
3 (9.7) 
3 (9.7) 
3 (9.7) 
2 (6.5) 
2 (6.5) 
2 (6.5) 
2 (6.5) 
2 (6.5) 
1 (3.2) 
1 (3.2) 
1 (3.2) 
1 (3.2) 
1 (3.2) 
1 (3.2) 
1 (3.2) 
1 (3.2) 
1 (3.2) 
1 (3.2) 
1 (3.2) 
1 (3.2) 
1 (3.2) 
1 (3.2) 
 1 (3.2) 
Data is presented as mean ±standard deviation or number (percentage), unless otherwise stated. 
Abbreviations: BMI, body mass index; FEV1, forced expiratory volume in one second; FVC, forced vital capacity, 
FEV1/FVC, ratio between FEV1 and FVC; MIP, maximal inspiratory pressure; MEP, maximal expiratory pressure. 
 
 
One patient at baseline and at discharge, and four patients at discharge 
assessments failed to perform the PEF and the PCF due to difficulties in assuming the 
sitting position due to skin damage (n=2) or because they refused to perform it (n=2). 
Therefore, 23 patients performed the PEF and the PCF at baseline and discharge. 
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Twenty-two patients (71%) reported pain at baseline. The most painful body 
regions were the lower limb (n=8; 25.8%), the upper limb (n=7; 22.6%), and the 
thoracolumbar region (n=7; 22.6%). 
After the rehabilitation programme, significant improvements were found for the 
NPRS (median difference of -1, with interquartile range of -3 points; p<0.001; effect size 
(ES)=-0.5), the PEF (mean difference of 46.1 L/min; p<0.001; ES=0.59), the PCF (21.3 
L/min; p=0.03; ES=0.37), the FSS (-0.5 points; p=0.03; ES=-0.27), and the leisure 
component of the LCADL (median difference of 0, with interquartile range of 1 point; 
p=0.02; ES=0.45). No other significant improvements were found. Baseline and post 
intervention scores can be found in Table 2. 
Table 2. Effects of the rehabilitation programme in patients with spinal cord injury (n=28). 
Outcome measure Baseline Post-
intervention 
Change p value Effect 
size 
NPRS, points (n=28) 7 [8] 4.5 [6] -1 [3] <0.001* -0.50 
      
PEF, L/m (n=23a) 
 
358.7 ± 99.6 404.8 ± 123.3 46.1 ± 51.3 <0.001* 0.59 
PCF, L/m (n=23a) 367.8 ± 
113.7 
389.1 ± 118.6 21.3 ± 43  0.03* 0.37 
 
FSS, points (n=27b) 
 
3.8 ± 2 
 
 
3.3 ± 1.8 
 
-0.5 ± 1.0 
 
0.03* 
 
-0.27 
LCADL, points (n=27b) 
          Self-care 
          Domestic 
          Physical 
          Leisure 
7.6 ± 3.5 
4 [0] 
0 [0] 
1 [1] 
2 [2] 
7.7 ± 3.2 
4 [1] 
0 [0] 
1 [1] 
2 [2] 
0.2 ± 2.1 
0 [1] 
0 [0] 
0 [0] 
0 [1] 
0.72 
0.17 
0.85 
0.25 
0.02* 
0.04 
-0.17 
0.04 
-0.14 
0.45 
Notes: Values are presented as mean ± standard deviation or median [interquartile range], unless otherwise stated. a5 
patients did not perform the test at discharge assessment; b1 outlier was removed; * p<0.05 
Abbreviations: NPRS, Numerical Pain Rating Scale; PEF, peak expiratory flow; PCF, peak cough flow; FSS, Fatigue 
Severity Scale; LCADL, London Chest Activities of Daily Living Scale; L/m, litters per minute. 
 
Participants were unable to complete the following activities in the LCADL at 
baseline: putting shoes/socks on (n=15, 48.4%), going out socially (n=21, 67.7%), 
walking in home (n=22, 71%), walking up stairs (n=25, 80.6%) and domestic activities 
(n=26, 83.9%). After the rehabilitation programme, 13 patients recovered some abilities, 
such as dressing  upper body (n=1, 3.6%), putting shoes/socks on (n=1, 3.6%), make 
beds (n=1, 3.6%), change sheet (n=1, 3.6%), wash up (n=2, 7.1%), bending (n=1, 3.6), 
walking up stairs (n=1, 3.6%), walking in home (n=3, 10.7%), and going out socially at 
the weekend (n=9, 32.1%).  
Comparing the LCADL score at admission and discharge, the results were not 
statistically significant (mean difference of 0.2 points; p=0.72; ES=0.04). However, 
almost half of the patients (n=13, 46.4%) were able to perform more activities at 
discharge, which increased their final score of the LCADL. After removing the activities 
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that scored “0” at baseline from the total score, there was a statistically significant 
improvement of dyspnoea during ADL (-0.6 points; p=0.008; ES=-0.19). 
 
 Minimal Clinically Important Difference 
 Anchor-based methods 
A negative and statistically significant correlation was found between the GRC 
and changes in the NRPS (r=-0.7; p=<0.001). No statistically significant correlations 
were found between the GRC and the PEF (r=-0.09; p=0.68), the PCF (r=-0.06; p=0.77), 
the FSS (r=-0.25-; p=0.21), and LCADL (r=-0.17, p=0.39; and r=-0.26, p=0.21 with the 
final score adjustment without the activities which scored 0 points at admission). Thus, 
anchor methods were only possible to be applied for the NRPS. 
In total, 17 patients (60.7%) perceived improvements higher than 2 points in the 
GRC for pain (NPRS mean difference of -2.9 ± 2.3), whereas 11 (39.3%) did not reach 
that threshold (NPRS mean difference of -0.1 ± 0.5). 
Using linear regression, the estimated MCID for the NPRS was -1.5 points 
(95%CI -2.9 to -0.1) (Figure 2). 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Linear regression to estimate the minimal clinically important difference for numerical 
pain rating scale according to the global rating of change, in patients with spinal cord injury (n=28). 
 
Using ROC statistics, the AUC generated for the NPRS did not show adequate 
discrimination between those improving above and below two points for the GRC 
(AUC=0.45; 95%CI=0.26 to 0.65; p=0.82), thus a MCID could not be computed using 
ROC methods. 
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Distribution-based methods  
The SEM, 1.96SEM, MDC95, and 0.5SD were calculated for the NPRS, PEF, 
PCF, FSS and LCADL. Distribution-based MCID estimates ranged from 0.8 to 2.3 points 
for the NPRS, 37 to 102.5 L/min for PEF, 59.4 to 166.5 L/min for PCF, 0.6 to 1.8 points 
for the FSS, and 0.6 to 2 points for the LCADL (Table 3). 
 
Table 3. Minimal clinically important difference distribution-based estimates for numerical pain 
rating scale, peak expiratory flow, peak cough flow, fatigue severity scale, and london chest 
activities of daily living scale in patients with spinal cord injury (n= 31). 
Outcome measure   SEM 1.96SEM MDC95 0.5SD 
NPRS, points (n=31) 0.8 1.7 2.3 1.8 
     
PEF, L/m (n=30a) 37 72.5 102.5 56.5 
 
PCF, L/m (n=30a) 60.1 117.7 166.5 59.4 
 
FSS, points (n=31) 
 
0.6 
 
1.2 
 
1.8 
 
0.9 
 
LCADL, points (n=31) 
          Self-care 
          Domestic   
          Physical  
          Leisure         
 
0.6 
3.3 
0.4 
1.4 
1.7 
 
 
1.3 
6.4 
0.7 
2.8 
3.4 
 
 
1.8 
0.3 
0.8 
0.2 
0.4 
 
2 
2.7 
0.4 
1.2 
1.5 
Notes: a1 patient did not perform the test at baseline. 
Abbreviations: NPRS, Numerical Pain Rating Scale; PEF, peak expiratory flow; PCF, peak cough flow; FSS, Fatigue 
Severity Scale; LCADL, London Chest Activities of Daily Living Scale; SEM, standard error of measurement; 1.96SEM, 
1.96 times SEM; MDC95, minimal detectable change; 0.5SD, 0.5 times standard deviation; ; L/m, litters per minute. 
 
Pooled MCID estimates for the clinical measures 
The weighted MCID estimates were -1.6 points for NPRS, 67.1 L/min for the PEF, 100.9 
L/min for the PCF, 1.1 points for the FSS (Figure 3), and 1.4 points for the LCADL (Figure 
4). Results for the LCADL dimensions were 3.2, 0.6, 1.4 and 1.8 points for self-care, 
domestic, physical, and leisure, respectively (Figure 4). 
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Figure 3. Pooled minimal clinically important difference (MCID) estimates for patients with spinal cord injury: a, numerical pain rating scale (NPRS) (n=31); b, 
peak expiratory flow (PEF) (n=30); c, peak cough flow (PCF) (n=30); and d, fatigue severity scale (FSS) (n=31). 
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Figure 4. Pooled minimal clinically important difference (MCID) estimates for patients with spinal cord injury: a, London Chest Activities of Daily Living Scale 
(LCADL) total score, b, LCADL, Self-care; c, LCADL, Domestic; d, LCADL, Physical; e, LCADL, Leisure (n=31). 
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DISCUSSION 
 
The present study established the MCIDs for NPRS, PEF, PCF, FSS, and 
LCADL. The distribution-based estimated values ranged from 0.8 to 2.3 points for NPRS, 
from 37 to 102.5 L/min for PEF, from 59.4 to 166.5 L/min for PCF, from 0.6 to 1.8 points 
for FSS, and from 0.6 to 2 points for LCADL. The pooled MCID estimates were -1.6, 
67.1, 100.9, 1.1 and 1.4 for NPRS, PEF, PCF, FSS, and LCADL, respectively. 
After the rehabilitation programme, significant improvements were found for 
NPRS, PEF, PCF, FSS, and the leisure component of LCADL. Medium ES were found 
for the NPRS and for the PEF, meaning that these outcome measures may be 
moderately sensitive to changes in patients with SCI who underwent a rehabilitation 
programme (Fritz, Morris, & Richler, 2011). A small ES was found for PCF, FSS, and 
LCADL, revealing poor sensitivity to change after the intervention (Fritz et al., 2011). No 
studies were found corroborating the positive results reported for pain, respiratory 
function and fatigue obtained after a comprehensive rehabilitation programme in patients 
with SCI. 
The results of LCADL were not statistically significant, suggesting that patients 
did not change their dyspnoea during ADL. However, these results need to be interpreted 
with caution as the domestic component of LCADL is not suitable to inpatients, and the 
scoring of LCADL is not well adapted to the expected functional improvement of patients 
with SCI, especially with motor incomplete injuries (AIS grades C and D) (Wilson et al., 
2012). At admission, most of our patients scored “0” in domestic activities, as they were 
inpatients and did not need to do it; and in the ADLs like putting shoes on, going out 
socially, walking in home, and walking up stairs; as they were unable to perform these 
activities due to motor impairments. Walking and going up stairs have been reported as 
the hardest items in other instruments such as the functional independence measure 
(FIM), or spinal cord independence measure (SCIM) self-report, assessing ADL in the 
SCI population (Bode, Heinemann, Kozlowski, & Pretz, 2014; Prodinger,et al., 2016). 
The SCIM was updated to SCIM III, an increasingly used scale of independence in the 
ADLs validated and designed for patients with SCI, with established  MCIDs after 
rehabilitation, for total score and for the respective subscales: self-care, respiration and 
sphincter management, mobility in the room, mobility indoors/outdoors) (Corallo et al., 
2017).  Nevertheless, some of our patients were able to do more activities by the end of 
the rehabilitation programme, and their score increased, not because they felt more 
dyspnoeic but because they were now doing more activities. Although, FIM and SCIM III 
have been used in this population, and spinal cord injury activities of daily living measure 
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(SCI_ADL) was recently developed, none of these measures assess dyspnoea impact 
on ADLs (Bode et al., 2014; Corallo et al., 2017; Li et al., 2018). We have chosen to use 
LCADL given the importance that dyspnoea might have on performing ADL in this 
population (Postma et al, 2016). However, the use of LCADL for routine clinical 
assessment in patients with SCI needs further reflection, as adaptions or different ADL 
measures might be necessary.  
The pooled MCID calculated for the NPRS was slightly higher than the one 
previously reported for patients with SCI specifically for back pain (MCID=-1.16) and 
similar to the one established for leg pain (MCID=-1.64) (Copay et al., 2008). Most of the 
patients included in our study performed a spine surgery before the rehabilitation 
programme, and the worst pain site referred at baseline was located in the lower limb, 
which possibly could have influenced the similarity between our MCID estimate for the 
NPRS and the MCID established for NPRS when assessing leg pain (Copay at al., 2008). 
No studies were found reporting MCIDs for PEF, PCF, FSS and LCADL in 
patients with SCI. MCID were only found in patients with laryngotracheal stenosis for the 
PEF (90 L/min) (Nouraei et al., 2014), with erythematous systemic lupus (ESL) for the 
FSS (0.4 points) (Pettersson et al., 2015) and in patients with COPD for the LCADL (4 
points) (Bisca, Proenca, Salomao, Hernandes, & Pitta, 2014). Overall, the values found 
for other populations tended to be higher than the ones reported in our sample. The 
functional impairment and treatment of patients with SCI is particularly different from 
patients with LS, ESL or COPD without neuromuscular conditions. Our pooled MCID 
estimates are dependent on the specific sample variability between patients with SCI, 
being different from the previously reported values for other populations (Copay et al., 
2008).  
It was not possible to use anchor-based methods to estimate MCIDs for PEF, 
PCF, FSS, LCADL due to non-significant correlations with GRC, in agreement with the 
results of a recent study, estimating MCIDs for COPD assessment test and clinical 
COPD questionnaire, reporting the design of the anchor questions as a possible reason 
(Alma et al., 2018). Designing appropriate anchors has been reported as a problem, 
since the patient-referencing anchor method is highly dependent on the correlation 
between the selected outcome measures and the anchor instrument; and on the 
accuracy of the anchor MCID (Revicki et al., 2006; Revicki et al., 2008). GRC may 
therefore not provide the best perception of change, due to patients limitation in recalling 
their health state at admission, being influenced by their current mood state, memory 
biases, and more recent health events (Crosby, Kolotkin, & Williams, 2003). Our MCIDs 
for PEF, PCF, FSS, LCADL were estimated with four distribution-based methods of 
baseline data, without influence from the intervention nor the patient perception of 
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change, which reduces the clinical significance (Alma et al., 2018; Oliveira et al., 2018). 
Nevertheless, in the absence of established MCID with anchor-based methods for 
patients with SCI, the MCIDs established may be carefully used to interpret the results 
post-intervention in future studies. 
 
Strengths and Limitations 
This study applied multiple anchor- and distribution-based approaches and 
determined the MCID for the NPRS, PEF, PCF, FSS, and LCADL in patients with SCI 
who participated in a rehabilitation programme. Estimates are valid for patients with 
traumatic and non-traumatic SCI, with different severity and neurological levels.  
There are however, some limitations that need to be acknowledged. First, 
involving only one investigator in the assessment and treatment of the patients, may 
influence patients’ answers, especially in questionnaires. This potential bias was 
minimised by following standard procedures when applying the different measures and 
active efforts were made not to influence patients’ answers. Secondly, a relatively small 
sample size to determine MCID was included in this study due to the timeframe and 
human resources constraints to perform this dissertation which may have reduced the 
strength of the statistical analysis (Terwee et al., 2007). Additionally, most studies 
measuring PEF and FSS revealed statistically significant differences between patients 
with complete or incomplete motor SCI, but our small sample size did not allow the 
discrimination of patients according to AIS, which may reduce the applicability of the 
MCID found in patients with different levels of SCI (Grimm, Schilero, Spungen, Bauman, 
& Lesser, 2006; Raab et al., 2016). Finally, the current study used distribution-based 
methods to estimate MCIDs for the PEF, PCF, FSS, LCADL, instead of using both 
distribution- and anchor-based approaches. However, this could not be performed due 
to the non-significant correlations between those outcome measures and GRC. Anchor-
based methods would enrich the estimated MCIDs with clinical significance, and 
probably the correlations with GRC would have improved with a higher sample size 
(Alma et al., 2018; Oliveira et al., 2018). 
 
Implications for future research, policy, and practice 
The present study established MCIDs for NPRS, PEF, PCF, FSS, and LCADL 
which can be used in clinical practice for patients with SCI. The interpretation of the 
results of rehabilitation programmes may now be guided considering the established 
MCID as a minimum goal to reach. Thus, the establishment of MCID for several outcome 
measures commonly used to assess patients with SCI may enable a better tailoring of 
measurable goals and treatment for patients. 
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More studies with larger samples are needed to increase the power in data 
analysis and potentiate reaching significant values in both anchor- and distribution-based 
approaches. Additionally, studies may explore the use of different anchors for PEF, PCF, 
FSS, and LCADL, possibly as the SCIM III (Corallo et al., 2017). A statistically signiﬁcant 
negative association was found between FVC and self-reported cough strength (p < 
0.0001) (Postma et al., 2016). FVC might therefore be a useful measure to be used as 
an anchor to estimate the MCID for PCF. Future studies should also discriminate patients 
with motor complete and incomplete SCI, since they present different functional 
prognosis, which may also influence the MCID.  
 
Conclusion 
Improvements exceeding -1.6 points on the NPRS, 67.1 L/min on the PEF, 100.9 
/min on the PCF, 1.1 points on the FSS, and 1.4 points on the LCADL may be considered 
clinically relevant for patients with SCI after a rehabilitation programme. 
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Termo de Consentimento Livre e Esclarecido 
 
Orientadora: Prof. Doutora Alda Sofia Pires de Dias Marques 
Coorientadora: Mestre Ana Luísa Araújo Oliveira 
Aluna de mestrado: Margarida de Almeida Santos Sobreira 
 
Por favor leia o que se segue e assine abaixo caso concorde com as 5 afirmações. (Caso 
não consiga assinar será pedido a uma testemunha externa ao estudo que assista a toda 
a explicação e assine por si caso consinta com os seguintes pressupostos) 
1. Eu confirmo que percebi a informação que me foi dada e tive a oportunidade de questionar e de me 
esclarecer. 
 
2. Eu percebo que a minha participação é voluntária e que sou livre de desistir, em qualquer altura, 
sem dar nenhuma explicação, sem que isso afete qualquer serviço de saúde ou qualquer outro que 
me é prestado. 
 
3. Eu compreendo que os dados recolhidos durante a investigação são confidenciais e que só os 
investigadores do projeto da Universidade de Aveiro têm acesso a eles. Portanto, dou autorização 
para que os mesmos tenham acesso a esses dados. 
 
4. Eu compreendo que os dados recolhidos durante o estudo podem ser utilizados para publicação em 
Revistas Científicas e usados noutras investigações, sem que haja qualquer quebra de 
confidencialidade. Portanto, dou autorização para a utilização dos dados para esses fins. 
 
5. Eu concordo então em participar no estudo.  
 
 
 
 
 
________________________ 
Nome do utente/ testemunha 
                     
 
 
 
 
 
 
_________ 
Data 
 
 
 
 
 
___________________________ 
Assinatura 
 
 
________________________ 
Nome da Investigadora 
 
 
_________ 
Data 
 
 
___________________________ 
Assinatura 
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Folha de informação ao participante 
O Sr./Sra. está a ser convidado/a para participar no estudo de investigação clínica 
intitulado: “Mínima diferença de importância clínica do débito máximo da tosse, débito expiratório 
máximo instantâneo, força muscular respiratória, escala de severidade da fadiga, escala London 
Chest Activities of Daily Living, e escala numérica da dor, em utentes com lesão medular”. Mas, 
antes de decidir, é importante que compreenda porque é que a investigação está a ser realizada 
e o que é que a mesma envolve. Por favor, leia a informação com atenção e discuta a sua 
participação com outros, se assim o entender.   
Se houver algo que não esteja claro para si ou necessitar de informação adicional, por 
favor pergunte aos investigadores (contactos no final deste documento). Use o tempo que 
precisar para decidir se deseja ou não participar.  
Muito obrigada desde já por ler a informação. 
 
Qual é o propósito do estudo? 
Este estudo visa quantificar a melhoria mínima que os utentes com lesão medular sentem 
como sendo importante após a fisioterapia. Estes valores, denominados valores de mínima 
diferença de importância clínica, serão estabelecidos para as alterações ao nível da função 
respiratória, força dos músculos respiratórios, intensidade da tosse, fadiga, dificuldade 
respiratória em atividades e dor. Após estabelecidos, estes valores serão muito úteis para os 
fisioterapeutas interpretarem os resultados da avaliação de utentes com lesão medular. 
Para que seja possível alcançar estes objetivos vimos então solicitar a sua participação 
neste estudo que será realizado no Centro de Medicina e Reabilitação de Alcoitão (CMRA) e na 
Escola Superior de Saúde da Universidade de Aveiro. 
 
Porque é que fui escolhido/a? 
Foi escolhido/a porque é um adulto (≥18 anos de idade) com lesão medular que fala e 
compreende o Português e está internado no CMRA. Para o estudo, precisamos de dados de 
aproximadamente 50 pessoas, com uma condição clínica semelhante à sua, que aceitem 
participar. 
 
Tenho de participar? 
A decisão de participar, ou não, é completamente sua. Se decidir participar vai-lhe ser 
pedido que assine um formulário de consentimento informado mas, é totalmente livre de desistir 
a qualquer momento, sem que para tal tenha de dar qualquer justificação. A decisão de desistir 
ou de não participar, não afetará a qualidade dos serviços de saúde ou qualquer outro, que lhe 
são prestados agora ou no futuro. 
 
O que me acontecerá caso decida participar? 
No início e no final do seu internamento, o cardiopneumologista fará consigo as provas 
de função respiratória e avaliará a força dos seus músculos respiratórios. Adicionalmente, o seu 
fisioterapeuta vai avaliá-lo. Estes procedimentos fazem parte da rotina habitual do serviço do 
CMRA. Se decidir participar neste estudo, algumas medidas adicionais simples e que não 
causam qualquer desconforto, ser-lhe-ão explicadas e efetuadas após ter concordado com as 
mesmas e assinado o consentimento informado. Após assinar e entregar aos investigadores o  
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consentimento informado, ser-lhe-á então feita uma avaliação do seu estado de saúde geral e a 
fisioterapeuta investigadora irá avaliar a intensidade da sua tosse, e da sua expiração máxima 
recorrendo a um instrumento simples que mede a quantidade e a velocidade de ar expirado pela 
boca através de um pequeno tubo, ao mesmo tempo que o nariz está tapado com uma mola. Irá 
preencher também 3 escalas através de uma entrevista com a fisioterapeuta investigadora, para 
avaliar a severidade da sua fadiga, a dificuldade respiratória em atividades e a sua dor. Estes 
procedimentos serão repetidos pouco antes da sua alta, idealmente após 8 semanas. 
Além disso, na data da avaliação final, a fisioterapeuta investigadora irá perguntar-lhe 
qual a sua perceção global de mudança relativamente à tosse, força da expiração, fadiga, 
dificuldade respiratória e dor, utilizando questões preparadas de acordo com a melhor evidência 
científica. 
 
Quais são os efeitos secundários, desvantagens e riscos se eu resolver participar? 
Não existem efeitos secundários, desvantagens ou riscos de participar no estudo. 
 
Quais são os possíveis benefícios se eu resolver participar? 
Será alvo de uma avaliação mais completa do funcionamento do seu aparelho 
respiratório, bem como do impacto deste na sua vida diária, e os dados poder-lhe-ão ser 
disponibilizados, caso tenha interesse.  
A longo prazo, a informação obtida neste estudo, através da sua participação, irá ajudar 
a estabelecer as mínimas diferenças de importância clínica para utentes com a sua condição, 
facilitando a monitorização da evolução e o planeamento da intervenção do fisioterapeuta nestes 
utentes de uma forma mais personalizada.  
 
A minha participação será confidencial?  
Toda a informação recolhida no decurso do estudo será mantida estritamente 
confidencial e o anonimato será garantido. Os dados recolhidos serão salvaguardados com um 
código e palavra-passe, para que ninguém o/a possa identificar. Apenas os investigadores do 
projeto terão acesso aos seus dados.  
 
O que acontecerá aos resultados do estudo? 
Os resultados do estudo serão analisados e incorporados em Dissertações de Mestrado 
e Teses de Doutoramento e alguns serão publicados em Jornais Científicos. No entanto, em 
nenhum momento o Sr./Sra. será identificado/a. Se gostar de obter uma cópia de qualquer 
relatório ou publicação, por favor diga à fisioterapeuta investigadora. 
 
Contactos para mais informações sobre o estudo 
Alda Marques, orientadora                                                                      Ana Oliveira, coorientadora 
Escola Superior de Saúde da Universidade de Aveiro,                                    e-mail: alao@ua.pt 
Telefone 234 372 462 
e-mail: amarques@ua.pt 
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Fisioterapeuta na Unidade de Fisioterapia do Serviço de Reabilitação 1 para adultos (CMRA) 
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